Skip to content
Search

Latest Stories

Legal battle threatens Indian tycoon Singhania's fortune

The dispute could result in Singhania forfeiting 75 per cent of his £1.1bn fortune

Legal battle threatens Indian tycoon Singhania's fortune

INDIAN tycoon Gautam Singhania, chairman and managing director of the Raymond Group, is facing potential financial turmoil amid a bitter divorce settlement with his wife, Nawaz Modi.

The high-profile dispute, involving the publicly listed Raymond Group, could result in Singhania forfeiting 75 per cent of his $1.4 billion (£1.1bn) fortune, the BBC reported.


Despite reports of potential settlement talks, sources close to Modi assert that she refuses to accept a lower settlement.

The ongoing mediation involves family members from both sides, and the 75 per cent figure remains on the table. Modi insists on establishing an irrevocable trust to secure the future for her two daughters.

Prominent Mumbai law firm partner Rishabh Shroff notes the increasing use of trusts among wealthy families to shield assets and businesses. Singhania favours a trust where he is the sole trustee, while Modi seeks a co-trustee role with specific rights, according to the report.

Amidst the legal battles, concerns arise about corporate governance at the century-old Raymond Group. Singhania's alleged domestic abuse towards Modi, highlighted by a viral video and disturbing claims, has raised questions about the company's leadership.

In response to the allegations, Singhania remained silent, emphasising the importance of maintaining his family's dignity.

Modi's accusations, including physical assault and a broken bone, have led to non-cognizable offences filed against Singhania.

Raymond's independent directors assert their commitment to protecting minority shareholders' interests. However, unresolved questions persist, particularly regarding Singhania's ability to manage the company amid personal distractions and potential criminal liability.

While the company's shares initially faced a decline, they have since rebounded. The dispute has ignited discussions about corporate culture and governance within family-run conglomerates in India.

Despite internal assurances of business as usual, the board's response and Modi's whistle-blowing actions have triggered calls for transparency.

Corporate governance experts express disappointment in the company's handling of the matter and emphasise the need for a thorough investigation.

As the legal battle unfolds, the impact on shareholders and the future ownership structure of Raymond remains uncertain. The complexity of Singhania's financial position, with a significant stake in Raymond, makes a swift resolution challenging.

Social commentator Shobhaa De highlights the prevalence of domestic violence in India's wealthiest families, calling it "corporate India's best-kept secret." The ongoing legal battle raises broader questions about the independence of board members and corporate culture within powerful entities.

The outcome of this high-stakes divorce settlement could redefine Singhania's legacy and shape the narrative of corporate governance in one of India's most prominent conglomerates, the report further said.

In 2019, Gautam had a dispute with his father Vijaypat who accused the son of cheating him out of an exclusive apartment and of unceremoniously kicking him out of the company offices.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less